Patients With Type II Diabetes Mellitus At A Tertiary Care Hospital: A Prospective Study On Anti-Diabetic Drug Prescribing Patterns

Main Article Content

Dr. Sumera Iram
Md Kabirul Arif
Kamal Hasan
Sk Soil Rana
Sahabuddin

Abstract

The main aim is to study on prescribing patterns of anti-diabetic drugs for patients with type- II diabetes mellitus. Out of 457 patients screened, 426patients were enrolled according to inclusion and exclusion criteria. Among them 62.44% were males and 37.55% were females. The study found to be a higher incidence of diabetes among elderly patients, with a high incidence in the age group between 41-60 years (50.70%) and followed by 61‑80 years (19.24%). The study resolved that most of the patients were suffering from diabetes for 5 to 10 years, 221 (73.94%) of duration years followed by 1 to 5 years, 94 (22.06%). A total of 1565 drugs were prescribed in the overall study period. 68.62% were diabetic drugs, 13.41% hypertensive drugs, 07.85% NSAIDs, 07.66% asthmatic drugs, 03.57% antidepressants, and 04.40% supplements of drugs. The study resolved that drugs were prescribed as monotherapy was 49.76%, two drug therapy were 36.61%, three-drug therapy were 08.45% and four-drug therapy was 05.16%. In this study, 426 anti-diabetic drugs prescribed, among that, the physician’s most well-liked single-drug therapy more than multiple drug therapy and also the most often prescribed category was Biguanides category of anti-diabetic agents. Among Biguanides, Metformin was the foremost often utilized anti-diabetic drugs. The foremost prevalent combination of the drug was a two-drug therapy of Biguanides +sulfonylureas, among these combinations, Metformin + Glimipride was the foremost often utilized anti-diabetic drugs. Followed by 3 drug therapy were Biguanides +sulfonyl ureas+ thiazolidinedione and 4 drug therapies were Biguanides + sulfonylureas + DPP 4 inhibitors + thiazolidinedione.Pharmacists can contribute drastically to promote the rational use of medicines, even in resource-limited settings. This, of course, requires strong collaboration between different institutions and commitments of the pharmacists to the cause. Pharmacist medication review, patient counseling and telephone follow-up can limit the Adverse Drug Reactions. Medication discrepancies before and after discharge were common targets of intervention.

Downloads

Download data is not yet available.

Article Details

How to Cite
Dr. Sumera Iram, Md Kabirul Arif, Kamal Hasan, Sk Soil Rana, & Sahabuddin. (2024). Patients With Type II Diabetes Mellitus At A Tertiary Care Hospital: A Prospective Study On Anti-Diabetic Drug Prescribing Patterns. Journal of Advanced Zoology, 45(3), 58–74. https://doi.org/10.53555/jaz.v45i3.4256
Section
Articles
Author Biographies

Dr. Sumera Iram

Assistant professor, Sree dattha institute of pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad,Telanagana

Md Kabirul Arif

Students, Sree dattha institute of pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad, Telanagana

Kamal Hasan

Students, Sree dattha institute of pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad, Telanagana

Sk Soil Rana

Students, Sree dattha institute of pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad, Telanagana

Sahabuddin

Students, Sree dattha institute of pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad, Telanagana

References

Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia. 2011;54:3022–7. [PubMed] [Google Scholar]

5th ed. Brussels, Belgium: International Diabetes Federation; 2011. [Last accessed on 2012 Jul 10]. International Diabetes Federation. IDF Diabetes Atlas. Available from: http://www.idf.org/diabetesatlas . [Google Scholar]

Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009;1:18–28. [PubMed] [Google Scholar]

Davis SN. Insulin, oral hypoglycemic agents, and pharmacology of the endocrine pancreas. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. United States of America McGraw-Hill; 2006. pp. 1613–45. [Google Scholar]

Powers AC. Diabetes mellitus. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Lango DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 16th ed. New york: McGraw-Hill; 2005. pp. 2152–80. [Google Scholar]

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854–65. [PubMed] [Google Scholar]

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53. [PubMed] [Google Scholar]

Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30:807–12. [PubMed] [Google Scholar]

Lafata JE, Dobie EA, Divine GW, Ulcickas Yood ME, McCarthy BD. Sustained hyperglycemia among patients with diabetes: What matters when action is needed? Diabetes Care. 2009;32:1447–52. [PMC free article] [PubMed] [Google Scholar]